Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 08637/0002.
Budenofalk 3mg Gastro-resistant Capsules
Budenofalk 3mg gastro-resistant capsules
budesonide
1. What Budenofalk 3mg capsules are and what they are used for
2. What you need to know before you take Budenofalk 3mg capsules
3. How to take Budenofalk 3mg capsules
4. Possible side effects
5. How to store Budenofalk 3mg capsules
6. Contents of the pack and other information
Budenofalk 3mg capsules contain the active substance budesonide, a type of locally acting steroid used to treat chronic inflammatory diseases of the intestine and the liver.
Budenofalk 3mg capsules are used in the treatment of:
Talk to your doctor before taking Budenofalk 3mg capsules if you have:
Budenofalk 3mg capsules are not suitable for patients with Crohn’s disease affecting the upper gastrointestinal tract.
Sometimes this disease may cause symptoms outside the intestine (e.g. affecting the skin, eyes and joints) which are unlikely to respond to this medicine.
Typical effects of cortisone preparations may occur which may affect all parts of the body, particularly when you take Budenofalk 3mg capsules at high doses and for prolonged periods (see section 4. Possible side effects).
Further precautions during treatment with Budenofalk 3mg capsules
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. In particular:
Some medicines may increase the effects of Budenofalk 3mg capsules and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).
If you take cholestyramine (for hypercholesterolemia and also used to treat diarrhoea) or antacids (for indigestion) in addition to Budenofalk 3mg capsules, take these medicines at least 2 hours apart.
Budenofalk 3mg capsules could affect the results of tests performed by your doctor or in hospital. Tell your doctor that you are taking Budenofalk 3mg capsules before any tests are carried out.
You should not drink grapefruit juice whilst you are taking this medicine as this can alter its effects.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
You should only take Budenofalk 3mg capsules during pregnancy if your doctor tells you to.
Budesonide passes in small amounts into the breast milk. If you are breast-feeding you should only take Budenofalk 3mg capsules if your doctor tells you to.
Budenofalk 3mg capsules are not expected to affect your ability to drive or operate machinery.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Take three capsules once daily in the morning or one capsule 3 times a day (morning, midday and evening), unless your doctor instructs you otherwise.
Duration of treatment
Your treatment should last about 8 weeks.
Treatment of acute inflammation
Take three capsules once daily in the morning, unless you doctor instructs you otherwise.
Maintenance treatment
Maintenance treatment should only be started if symptoms reappear after stopping initial therapy. Depending on the course of your illness, your doctor will decide how many capsules you should take per day. Usually, the dose is two capsules once daily in the morning (a total of 6 mg budesonide per day). Alternatively, take two capsules in the morning on the first day and one capsule in the morning on the second day (corresponding to an average amount of 4.5 mg budesonide per day). Continue taking your medicine alternating the daily dose of two capsules and one capsule.
Duration of treatment
Treatment of acute inflammation should last about 8 weeks. The duration of maintenance treatment is determined by your doctor. Maintenance treatment is normally administered for up to 12 months. If it is indicated, your doctor may extend the treatment duration.
Treatment of acute inflammation
Take one capsule 3 times a day (morning, midday and evening), unless your doctor instructs you otherwise. Depending on the results of laboratory examinations, your doctor will decide how long you should take three capsules per day.
Maintenance treatment
Take one capsule 2 times a day (morning and evening), unless your doctor instructs you otherwise. Depending on the results of laboratory examinations, your doctor will decide how long you should take two capsules per day.
Please note that in most cases your doctor will prescribe Budenofalk 3mg capsules together with azathioprine, a medicine that works by reducing the body's immune response.
Duration of treatment
Depending on the results of examinations of your blood and liver tissue, your doctor will decide how long you should take this medicine and how many capsules per day you should take.
Budenofalk 3mg capsules should NOT be used in children under 12 years of age.
There is only limited experience with the use of this medicine in children older than 12 years of age.
Budenofalk 3mg capsules are for oral use only.
The capsules are to be swallowed whole, with a glass of water about ½ hour before meals. Do not chew the capsules.
If you have taken too much medicine on one occasion, take your next dose as prescribed. Do not take a smaller amount. Contact a doctor if you are in doubt, so he or she can decide what to do; take the carton and this leaflet with you if possible.
If you miss a dose, just continue your treatment at the prescribed dosage. Do not take a double dose to make up for a forgotten dose.
Speak to your doctor if you want to interrupt or end your treatment early. It is important that you do not stop taking your medicine suddenly as it could make you ill. Keep taking your medicine until your doctor tells you to stop, even if you start to feel better.
Your doctor will probably want to reduce your dose gradually over the course of two weeks.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have also been reported:
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
These side effects are typical of steroid medication and most of them can also be expected for treatments with other steroids. They may occur depending on your dose, duration of treatment, whether you have had or are having treatment with other cortisone preparations, and your individual susceptibility.
If you have been treated with a stronger cortisone preparation before starting treatment with Budenofalk 3mg capsules, your symptoms may reappear when the medicine is changed.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system:
Ireland
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton and blister pack. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is budesonide. Each capsule with gastro-resistant pellets contains 3 mg of budesonide.
The other ingredients are ammonio methacrylate copolymer (type A) (Eudragit RL), ammonio methacrylate copolymer (type B) (Eudragit RS), lactose monohydrate, maize starch, methacrylic acid-methyl methacrylate copolymer (1:1) (Eudragit L 100), methacrylic acid-methyl methacrylate copolymer (1:2) (Eudragit S 100), povidone K25, purified water, sucrose, talc, triethyl citrate, gelatin, erythrosine (E127), titanium dioxide (E171), red and black iron oxide (E172), sodium laurilsulphate (see also end of Section 2 for further, important information on lactose and sucrose).
Budenofalk 3mg capsules are pink coloured gastro-resistant hard capsules contained in blister strips.
Budenofalk 3mg capsules are available in pack sizes of 10, 50, 90, 100 or 120 – not all may be marketed.
This medicinal product is authorised in the Member States of the EEA under the following names:
Denmark, Finland, Ireland, Sweden, United Kingdom: Budenofalk
France: MIKICORT
Italy: Intesticort
Spain: Intestifalk
This leaflet was last revised in 12/2019.